How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

DR

NASDAQ:DRIO
Get a brief AI stock analysisSaves ~ 15 minutes of your time

DR

DarioHealth CorpNASDAQ DRIO Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is DRIO undervalued compared to its fair value?

The fair value of DRIO stock is hidden USD. Relative to the market price of 1.22 USD DarioHealth Corp is hidden.

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 241 full...[More about valuation]

DarioHealth Corp Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.037 $B

Price:

1.22 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.267

FINANCIALS

DarioHealth Corp financial for reporting period

Income Statement

0.0058 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.018 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0092 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0058 B 100%
0.0024 B 42%
-0.018 B -310%
-0.0092 B -160%

Balance Sheet

0.14 B
0.078 B

0.028 B

Financial Position Analysis

Assets

0.14 B
Current Assets
0.053 B
Total non-current assets
0.084 B

Total current liabilities
0.018 B
Total non-current liabilities
0.041 B

Cash Flow Statement

-0.013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

DarioHealth Corp fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-85 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-92 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-52 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

DarioHealth Rating

Is DRIO attractive for investment based on fundamental analysis?

DRIO stock rating is hidden. DarioHealth Corp is a hidden by Eyestock methodology.

Get DRIO Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-315

Gross Margin:

28

CFO / Debt ratio:

hidden

Current ratio:

4.771

Debt / Equity ratio:

0.407

ROE:

-85

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

DRIO analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for DRIO to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

DarioHealth Corp dividends

DRIO dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About DRIO stock

About the company DarioHealth Corp

Market cap $B

0.037

Dividend yield

Shares outstanding

25.8719 B

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 241 full-time employees. The company went IPO on 2013-03-08. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Its products include Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. Its Dario Blood Glucose Monitoring Starter Kit is pocket-sized smartphone blood glucose meter that measure sugar levels. Its Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all your readings in the Dario App. Its Dario mobile application, the Dario Blood sugar (glucose) meter enables to track and check blood sugar (glucose) in real-time.

DRIO profile

  • Ticker

    DRIO

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    08 March 2013

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

    241

  • City

    New York City

  • Address

    18 W 18Th St., 5Th Floor

  • Cusip

    23725P209

Frequently Asked Questions

What sector does DarioHealth operate in?

DarioHealth operates in Healthсare sector

What is market cap of DarioHealth?

Market cap of DarioHealth is 0.037 USD as of 24 Jul 2024

What is market price of one DRIO stock?

Market price of one DRIO stock is 1.22 USD as of 24 Jul 2024

What is DarioHealth revenue?

According to the recent report DarioHealth revenue is 5.758

What is DarioHealth net income?

According to the recent report DarioHealth net icnome is -9.209

What is DarioHealth net income growh rate?

Net income growth rate of DarioHealth is 43